Diagnostic testing for Graves' or non-Graves' hyperthyroidism: A comparison of two thyrotropin receptor antibody immunoassays with thyroid scintigraphy and ultrasonography

被引:47
|
作者
Scappaticcio, Lorenzo [1 ,2 ,3 ]
Trimboli, Pierpaolo [2 ,3 ]
Keller, Franco [4 ]
Imperiali, Mauro [4 ]
Piccardo, Arnoldo [5 ]
Giovanella, Luca [2 ,3 ,4 ,6 ,7 ]
机构
[1] Univ Campania L Vanvitelli, Unit Endocrinol & Metab Dis, Naples, Italy
[2] Imaging Inst Southern Switzerland, Clin Nucl Med, Bellinzona, Switzerland
[3] Imaging Inst Southern Switzerland, Competence Thyroid Ctr, Bellinzona, Switzerland
[4] Ente Osped Cantonale, Inst Lab Med, Bellinzona, Switzerland
[5] Ente Osped Galliera, Div Nucl Med, Genoa, Italy
[6] Univ Hosp, Clin Nucl Med, Zurich, Switzerland
[7] Univ Zurich, Zurich, Switzerland
关键词
hyperthyroidism; thyroid scintigraphy; thyroid ultrasonography; thyroid-stimulating immunoglobulins (TSI); thyrotropin receptor antibodies (TRAb); DIFFERENTIAL-DIAGNOSIS; PAINLESS THYROIDITIS; CLINICAL UTILITY; CUTOFF VALUE; DISEASE; ASSAY; POPULATION; MANAGEMENT; BIOASSAYS; FLOW;
D O I
10.1111/cen.14130
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective: Graves' disease (GD) is the most common cause of hyperthyroidism. In many cases, when the aetiological diagnosis of GD is not evident based on the clinical evaluation and thyroid function testing, it may become challenging to distinguish Graves' hyperthyroidism from other forms of thyrotoxicosis. The current study was primarly carried out to compare the diagnostic effectiveness of two TSH receptor antibody immunoassays (IMAs), ultrasonography and thyroid scintigraphy in hyperthyroidism scenario. Methods: We retrospectively analysed consecutive patients with newly diagnosed and untreated thyrotoxicosis who underwent thyroid functional tests, both TRAb and TSI measurements, thyroid scintigraphy and ultrasonography. TRAb assessment was carried out by Kryptor (R) compact PLUS, while TSI by Immulite (R). Echo pattern 3 corresponded to 'thyroid inferno', and the final diagnosis of GD vs non-Graves' hyperthyroidism was made according to the thyroid scan (qualitative scintigraphy). Receiver operating characteristic (ROC) curves were drawn using the final diagnosis as reference. Clinical sensitivity and specificity, accuracy, positive predictive value (PPV) and negative predictive value (NPV) were calculated for all the tests. Results: A total of 124 untreated hyperthyroid patients were included in our study (GD, n = 86 vs non-Graves' hyperthyroidism, n = 38). ROC curves showed that the optimal cut-off values associated with the highest diagnostic sensitivity and specificity was 0.7 IU/L for TRAb Kryptor (R) (93 [85.4-97.4] and 86.8 [71.9-95.5]) and 0.1 IU/L for TSI Immulite (R) (94.2 [86.9-98.1] and 84.2 [68.7-93.9]), respectively. For the echo pattern 3, we found a good sensitivity (92.1%) and a high PPV (95.2%) but a quite low specificity value (69.8%) and a relative low NPV (57.5%). For thyroid scintigraphy, the TcTU cut-off value of 1.3% corresponded to the best limit for sensitivity and specificity in our patients (95.3 [88.5-98.7] and 96.4 [81.6-99.4]). The Passing-Bablok regression equation and the Bland-Altman test showed a great degree of correlation and agreement existed between TRAb Kryptor (R) and Immulite (R) TSI results. Conclusions: Thyroid scintigraphy remains the most accurate method to differentiate causes of thyrotoxicosis. However, TRAb assays can be alternatively adopted in this setting, limiting the use of thyroid scintigraphy (TcTU evaluation) to TRAb-negative patients. Thyoid US is less accurate than both TRAb/TSI and thyroid scintigraphy, but the 'thyroid inferno' pattern provides a high PPV for GD.
引用
收藏
页码:169 / 178
页数:10
相关论文
共 36 条
  • [1] Clinical diagnosis of Graves' or non-Graves' hyperthyroidism compared to TSH receptor antibody test
    Bell, Lauren
    Hunter, Ann Louise
    Kyriacou, Angelos
    Mukherjee, Annice
    Syed, Akheel A.
    ENDOCRINE CONNECTIONS, 2018, 7 (04): : 504 - 510
  • [2] Clinical utility of TSH receptor antibody levels in Graves' orbitopathy: a comparison of two TSH receptor antibody immunoassays
    Bluszcz, Gabriela A.
    Bednarczuk, Tomasz
    Bartoszewicz, Zbigniew
    Kondracka, Agnieszka
    Walczak, Klaudia
    Zurecka, Zuzanna
    Demkow, Urszula
    Misikiewicz, Piotr
    CENTRAL EUROPEAN JOURNAL OF IMMUNOLOGY, 2018, 43 (04) : 405 - 412
  • [3] Significance of Thyroid-Stimulating Immunoglobulin and Thyrotropin Receptor Antibody in Graves Disease
    Peng, Rongguang
    Xie, Pu
    Jin, Zhou
    Zhou, Wenzhong
    Wang, Yanqiu
    Chen, Xinxin
    Yin, Qinglei
    Shen, Liyun
    Meng, Lingyang
    Ye, Lei
    Zhou, Yulin
    Wang, Shu
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2025,
  • [4] Thyroid-stimulating antibody is related to Graves' ophthalmopathy, but thyrotropin-binding inhibitor immunoglobulin is related to hyperthyroidism in patients with Graves' disease
    Noh, JY
    Hamada, N
    Inoue, Y
    Abe, Y
    Ito, K
    Ito, K
    THYROID, 2000, 10 (09) : 809 - 813
  • [5] The effect of changes of serum thyrotropin receptor antibody on the outcome of radioactive iodide therapy for Graves' hyperthyroidism
    Nakada, Kunihiro
    Mizukoshi, Tsunenori
    Hattori, Naoya
    Tamura, Mika
    Kato, Katsuhiko
    Kato, Noriyoshi
    JOURNAL OF NUCLEAR MEDICINE, 2020, 61
  • [6] The Mediation Role of Thyrotropin Receptor Antibody in the Relationship Between Age and Severity of Hyperthyroidism in Graves' Disease
    Suzuki, Nami
    Inoue, Kosuke
    Yoshimura, Ran
    Kinoshita, Aya
    Suzuki, Ai
    Fukushita, Miho
    Matsumoto, Masako
    Yoshihara, Ai
    Watanabe, Natsuko
    Noh, Jaeduk Yoshimura
    Katoh, Ryohei
    Sugino, Kiminori
    Ito, Koichi
    THYROID, 2022, 32 (10) : 1243 - 1248
  • [7] The diagnostic criteria of Graves' disease and especially the thyrotropin receptor antibody; our own experience
    Paunkovic, Nebojsa
    Paunkovic, Jane
    HELLENIC JOURNAL OF NUCLEAR MEDICINE, 2007, 10 (02): : 89 - 94
  • [8] Evaluation of analytic and clinical performance of two immunoassays for detecting thyroid-stimulating receptor antibody in the diagnosis of Graves' disease
    Hu, Yao
    Ni, Jiajin
    Cen, Yi
    Zhang, Buyue
    Wu, Wenqing
    Cheng, Wei
    Huang, Mingying
    Guan, Ming
    JOURNAL OF CLINICAL LABORATORY ANALYSIS, 2021, 35 (12)
  • [9] CHANGES IN THYROTROPIN RECEPTOR ANTIBODY AFTER SUBTOTAL THYROIDECTOMY IN GRAVES-DISEASE - COMPARISON WITH THE DEGREE OF LYMPHOCYTIC INFILTRATION IN THE THYROID
    CHO, BY
    OH, SK
    SHONG, YK
    KIM, SE
    YOO, HY
    LEE, HK
    KOH, CS
    MIN, HK
    AUTOIMMUNITY, 1990, 8 (02) : 143 - 147
  • [10] THYROTROPIN RECEPTOR NON-MEDIATED THYROID STIMULATING IMMUNOGLOBULIN IN GRAVES-DISEASE
    ENDO, T
    HARAGUCHI, K
    OHMORI, M
    IKEDA, M
    OHTA, K
    ONAYA, T
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1991, 179 (03) : 1543 - 1547